The Chemours Company (NYSE:CC) Receives $18.40 Average Target Price from Analysts

Shares of The Chemours Company (NYSE:CC) have received an average rating of “Hold” from the twelve analysts that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $18.40.

CC has been the subject of a number of recent analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Chemours in a research report on Wednesday, January 21st. BMO Capital Markets reduced their target price on Chemours from $20.00 to $19.00 and set an “outperform” rating on the stock in a report on Monday, February 23rd. UBS Group boosted their target price on Chemours from $18.00 to $23.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Royal Bank Of Canada restated an “outperform” rating and issued a $18.00 price target on shares of Chemours in a report on Friday, January 16th. Finally, The Goldman Sachs Group raised their price target on Chemours from $14.00 to $18.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 25th.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of CC. Baird Financial Group Inc. bought a new stake in shares of Chemours during the first quarter worth $148,000. Royal Bank of Canada lifted its position in Chemours by 6.8% in the 1st quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company’s stock valued at $7,926,000 after acquiring an additional 37,382 shares in the last quarter. AQR Capital Management LLC bought a new stake in Chemours in the 1st quarter valued at $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Chemours by 149.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company’s stock worth $593,000 after purchasing an additional 25,899 shares during the period. Finally, Empowered Funds LLC acquired a new position in Chemours in the 1st quarter worth $403,000. Institutional investors own 76.26% of the company’s stock.

Chemours Stock Up 3.9%

Chemours stock opened at $21.58 on Tuesday. The firm has a market capitalization of $3.24 billion, a price-to-earnings ratio of -8.70 and a beta of 1.60. The company’s 50 day simple moving average is $17.88 and its 200 day simple moving average is $15.09. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.78 and a quick ratio of 0.85. Chemours has a fifty-two week low of $9.13 and a fifty-two week high of $21.85.

Chemours (NYSE:CC) last issued its earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.01 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.33 billion. Chemours had a negative net margin of 6.41% and a positive return on equity of 41.75%. The business’s quarterly revenue was down 2.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.09 earnings per share. As a group, sell-side analysts anticipate that Chemours will post 2.03 EPS for the current year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Friday, February 27th were paid a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date of this dividend was Friday, February 27th. Chemours’s dividend payout ratio is presently -14.11%.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.